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Attracting financial support is a critical element of success in science, but we have entered a time of cost constraint with
little hope of relief coming soon. For principal investigators, developing a broad base of research support is a valuable
strategy for attaining financial stability for the laboratory. New investigators working on problems related to virulence
and just beginning to build their careers and laboratories must attain NIH funding. But they should also look beyond that
agency to the other federal organizations, state and regional agencies, and non-profits that support research. This review
will discuss the general principles of how to understand funders, their intentions, and their funding programs. An
investigator who grasps what drives the funders will be better able to write fundable proposals.
Investigators at mid-career and beyond are
seeing well-established lines of research go
unfunded, disrupting productive laborat-
ories and potentially bringing careers to an
end.
1,2 Institutions have little margin for
sustaining science without grant dollars
coming in.
3 For researchers just beginning
their independent careers, building a
diversified funding portfolio is a good
strategy for keeping a laboratory financially
healthy for the long-term. Researchers who
have several lines of funding, even if some
of those lines are small, should be more
able to thrive in tough times than those
who rely entirely on the National
Institutes of Health (NIH).
This review is written with new inves-
tigators in mind, and when the word
“you” is used in the material that follows,
they are the ones being addressed. The
review focuses on understanding the
spectrum of funders who may support
your work and on what makes a successful
grant application. Understanding which
funders do what, and why, is the key to
establishing multiple sources of income
for your laboratory. Because the NIH is
the major supporter of most researchers
working on topics related to Virulence,
grants from that agency, and particularly
from the National Institute of Allergy and
Infectious Disease (NIAID) will be the
source for much of the information here,
but opportunities and procedures found at
other agencies, including other federal
organizations [particularly the National
Science Foundation (NSF)], private foun-
dations, and voluntary health organiza-
tions will also be discussed. Researchers
should note that while the funders of
science are different in ways that are
important, with few exceptions the major
funders of research share the research
community’s commitment to peer review
and to transparency in the funding pro-
cess. Agencies that predominantly use
non-peer review approaches, for instance,
the Defense Advanced Research Projects
Agency (DARPA), are important, as well.
The bibliography references several good
published reviews and commentaries on
the mechanics of grants
4,5 and getting
grants to support basic,
6,7 clinical
8-10 and
translational
6,11 research.
NIH itself is a particularly good source
of information on gaining the Institutes’
grants. The NIAID Funding Newsletter
ran a well written and comprehensive set
of 24 articles on designing a project and
seeking funding from the Institute, The
New Investigators Series in 2010–2011.
This series has now been consolidated
under the title Strategy for NIH Fund-
ing,
12 and is essential reading for those
who hope to obtain funding from NIAID.
Ten years ago, it would have been
unthinkable to define a good attempt at
getting a grant as anything other than one
that yielded funding. But the current
scarcity of resources leaves high-quality
proposals unfunded, so perhaps a new
definition is warranted. The funding rate
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of new proposals has dropped over the last
decade (see Table1), but the mental work
involved in creating a new funding appli-
cation is valuable whether the proposal is
funded or not. It is never a mistake to
think hard about one’s work, or to define
new ways to move forward. Without
claiming that an unfunded grant applica-
tion is a successful one, this review will
outline ways to ensure that time spent
going after a grant is productive, even if
there is no funding.
Building a Funding Portfolio
While some just-hired assistant professors
bring postdoc-to-faculty bridging awards
with them as they leave their postdoctoral
training, for most new investigators, the
institutional start up package negotiated
as part of the hiring process serves as the
equivalent of a first exploratory grant.
Your startup funds provide resources for
getting early data that will serve as a plat-
form to support your first independent
research project grants.
The small dollars. As you begin to
build your lab group, you will take on
postdocs and graduate students who
themselves will eventually need to build a
track record of finding funding and doing
independent work. Establishing a preced-
ent in your lab that trainees will actively
seek out funding will allow you to give
your students and postdocs a rare training
experience. If they are successful in finding
support, your own limited funds will
stretch further. A number of resources
are available to help postdocs and fel-
lows
13-15 look for support of their own.
Though most research institutions
today are financially stressed, your insti-
tution may have dollars available for
encouraging collaboration between inves-
tigators at home, stimulating the use of
core facilities, or developing new research
projects. Participation in relevant centers
within your institution can give you access
to resources and funding. Departmental
colleagues can be a good source of
information about this type of funds, but
so can colleagues in far-flung departments.
If your appointment is in a medical school
but strong research is also being done
within other colleges within your insti-
tution, investigators in the non-medical
departments may be aware of institutional
resources that are not commonly used by
your closer colleagues. Browsing your
institution’s internal newsletter regularly
will help you become aware of opportun-
ities, including some that are directly
advertised and others that will be reported
on as colleagues across the institution
make use of them. Your department chair
or assigned mentor can help you under-
stand which of these small pots of money
are appropriate or inappropriate for you
to seek, and should help you weigh the
costs and benefits of getting involved in
collaborative programs and centers during
your early faculty years.
Local organizations also may have small
funding opportunities that can help you
accomplish more. The nearby chapter(s) of
Sigma Xi, the scientific research honorary
society, likely runs a graduate student
research day. Prizes at different chapters
range from book awards to research prizes
of $1,000 or more that can cover the
student’s travel to meetings or reagents
required for his or her project. Sigma Xi
also makes available its student-focused
Grants-in-Aid of Research program. This
program provides up to $1,000 that can
also support purchase of specific equip-
ment needed for a student’s project,
reagents and supplies that are not typically
in your laboratory, or travel to and from a
research site.
Local community foundations, which
provide philanthropic services giving local
donors the capacity to create permanent
endowments in their areas of interest,
also in some cases have small grants that
support science. Donors who have lost a
loved one to a particular disease, for
example, may establish an endowment
that generates money for research toward
a cure. Though there is usually not a lot
of money in these grants, this is a potent-
ial funding source that is overlooked by
most academics, so it is well worth
searching your local community founda-
tion’s database of funding opportunities
to see if they list anything that will fit
your work. Community foundations also
frequently support scholarships. Especially
in regions where scientific research and
technology play an important part in the
economy, there may be endowments set
up by scientist donors to support graduate
students for travel and participation in
courses, meetings, and off-site research.
State level funding also frequently exists,
particularly for technology development
that could bring new industry to your
region. This kind of funding can be use-
ful as you are establishing a laboratory,
supporting, for example, pilot projects
on a microbial or host factor that could
be useful for developing diagnostic tools.
A number of strong research institutions
are located in states that benefit from the
National Science Foundation’s (NSF’s)
Experimental Program to Stimulate Com-
petitive Research (EPSCoR),
16 which pro-
vides states that have lower capacity in
Table1. NIAID funding of new R01s and R01 renewals, FY2001–2010
Year New
proposals
reviewed
New
proposals
funded
New
proposals
funding rate
Renewal
proposals
reviewed
Renewal
proposals
funded
Renewal
funding
rate
2001 1421 395 27.8% 415 234 56.4%
2002 1488 380 25.5% 440 214 48.6%
2003 1584 439 27.7% 493 258 52.3%
2004 2061 389 18.9% 518 231 44.6%
2005 2107 425 20.2% 571 215 37.7%
2006 2186 369 16.9% 640 216 33.8%
2007 2087 326 15.6% 619 174 28.1%
2008 1951 333 17.1% 628 200 31.8%
2009 1917 339 17.7% 564 176 31.2%
2010 2097 355 16.9% 521 197 37.8%
Data taken from NIH Reporter Table #206, Research Project Grants (RPGs): Competing Applications,
Awards, Success Rate and Total Funding by Application Type, NIH Institutes/Centers and Activity Code
Fiscal Years 2001–2010.
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research and development with support
meant to stimulate improvements in their
capacity and competitiveness. EPSCoR
supports infrastructure development and
proposals from individual investigators,
groups, and centers. States where you can
take advantage of EPSCoR funding
include Nevada, Utah, New Mexico,
Idaho, Montana, Wyoming, the Dakotas,
Iowa, Nebraska, Oklahoma, Arkansas,
Mississippi, Louisiana, Alabama, Tennessee,
South Carolina, Kentucky, West Virginia,
Maine, Vermont, New Hampshire, Alaska,
Hawaii, and Puerto Rico.
In many fields, there are funding organi-
zations that support small but important
projects. The National Oceanographic and
Atmospheric Administration’s Sea Grant
network, 32 state-based programs around
the coastal United States including the
Great Lakes states, for example, is a
potential source of funding for some
work related to water-borne diseases and
microbial contaminants of coastal waters.
The Morris Animal Foundation supports
work on animal health with young
investigator awards. Pay attention to the
acknowledgments in papers in your field
to identify others.
The bread and butter. Investigators
who are new to their faculty careers are
successfully establishing NIH funding,
sometimes with significant help from
agency strategies that improve new inves-
tigators’ chance of being funded. The
Research Project Grant (R01) is the oldest
of NIH’s grant mechanisms. It usually
supports a specific, well defined research
project performed by an investigator or a
small group of investigators. NIH cur-
rently sets the R01 payline, the percentile-
based funding cutoff point that reflects
an Institute’s budget and the number
of proposals expected, higher (easier to
achieve) for new investigators than for
those who have successfully competed for
NIH support. In 2011, NIAID’s R01
payline was 10% for established investiga-
tors and 14% for new investigators.
17 New
investigator applications are often reviewed
together so they are not evaluated sand-
wiched between proposals written by those
with more experience soliciting funding
from the agency. When considering grants
from new investigators, reviewers consider
the applicant’s potential as well as his or
her track record. All of these factors lower
the barrier for getting one’s first major
NIH grant, usually an R01. There is no
extra boost when it comes time for
competitive renewal of these first R01s,
so in a few years the now newly funded
will face the same lower payline as other
established investigators.
NSF has a freestanding program for
those just starting out, the Faculty Early
Career Development (CAREER) pro-
gram.
18 Biological science focused awards
from this program carry a minimum
budget of $500,000 over five years—
$100,000/year. There is no maximum
budget, but budgets must be appropriate
for the work proposed and the five year
term of support. CAREER awards go to
junior faculty who integrate their roles as
researchers and educators. These grants
can support research in any of the scienti-
fic areas that the Foundation funds. NSF
grant support is important to health sci-
ence research in areas including develop-
ing animal models, developing molecular
tools, understanding regulation of biologi-
cal processes, and more. Health focused
grants do not compete well for NSF
grants, but in your early career it may be
possible for you to develop lines of
research that are broad enough to merit
NSF funding and that complement the
health oriented work you plan to build
with NIH and other support.
NSF also has available small grants for
high risk research. The Small Grants for
Exploratory Research (SGER) mechanism
supports pilot work, high risk/high pay-
off work, transformative ideas and work
that could change its field or rapidly move
its field forward.
19 Because innovation is
a key element, it is best to discuss your
ideas with the program officer before you
begin writing so that you can make sure
that what you are planning is appropriate
for this kind of support. SEGR grants are
normally for one year but can be for
two. They can carry a budget of up to
$200,000 but are generally substantially
smaller than the typical grant within a
given program area.
Other federal agencies may also be
important potential supporters of your
work. Research!America counts 16 federal
agencies among major supporters of health
research
20 (see Table2). Department of
Energy’s (DOE’s) Biological Systems
Science Division (BSSD),
21 for example,
supports university and research institute
based work in many fields including
genomic science, radiochemistry, and
structural biology. The agency’s world-
leading capacity in high performance
computing makes it a valuable partner
for modeling work whether at the mole-
cular scale, the ecosystem scale, or
beyond.
22 DOE funding supports research
at the agency’s own laboratories, at user
facilities where infrastructure is shared
with other researchers from various sectors,
and through competitive grant programs
that are announced at grants.gov, the
online clearinghouse that lists all federal
grant opportunities.
The Department of Veterans Affairs
(VA) is an important supporter of work
in many significant microbial pathogens.
While most VA-supported work is per-
formed by the agency’s intramural staff at
VA centers around the country, some
Table2. Federal support of health science
research
Federal agency Support
per year,
$Millions
National Institutes of Health 34,829
National Science Foundation 2,914
Department of Defense 2,667
Department of Agriculture 1,265
Department of Energy 1,037
Environmental Protection Agency 596
Department of Commerce 588
Department of Veterans Affairs 581
Centers for Disease Control and
Prevention
363
Food and Drug Administration 248
Department of Homeland
Security
207
Department of the Interior 205
NASA 182
US. Agency for International
Development
158
Centers for Medicare and
Medicaid Services
27
Health Resources and Services
Administration
8
Source: Research!America US. Investment in
Health Research, 2010.
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work offsite is also allowed when the
non-VA site provides unique research
opportunities for VA investigators.
23
Collaborations with VA scientists around
a technique or technology that is based
in your lab will not bring you grants from
the VA, but may give you opportunities
to develop new projects or venture into
work with new microbes that may open
up for you new areas of funding from
other agencies.
Grant recipients and intramural scien-
tists from 11 federal agencies including
NSF, the Department of Health and
Human Services through NIH, the
National Aeronautics and Space Admini-
stration, the Environmental Protection
Agency, the Department of Energy and a
number of other agencies that support at
least some life science research are eligible
for the Presidential Early Career Award
for Scientists and Engineers (PECASE),
24
a program that recognizes and honors top
early career faculty who have exceptional
potential to break new scientific ground
and become the leaders of their fields.
NSF nominees for this award come from
the population supported by CAREER
awards, and NIH nominees come from
among funded junior faculty and from
the agency’s intramural staff. While the
award does not bring with it any addi-
tional funding, recognition through a
PECASE is arguably the top honor
available to junior faculty.
Private sources of funds will also help
you build a solid funding portfolio. Private
foundations (see Table3), which support
research with the income from endow-
ments or with direct donations, and public
charities, which make grants with money
raised from the public, are significant
supporters of research. Many have pro-
grams aimed at supporting the careers of
new investigators, often explicitly viewing
early investment in your career as a
strategy for drawing you into and keeping
you engaged in work focused on the
problems that the funding organization
serves.
Public charities include a number of
organizations known as “voluntary health
agencies,” which have long histories
focused on important infectious disease
public health problems including tuber-
culosis,
25 polio,
26 AIDS
27 and more. The
American Heart Association, which started
as a scientific and medical professional
society, became a voluntary health agency
in 1946
28 in part so it could support
research, in part to do charitable work for
those afflicted with heart disease, in part
to affect public policy, and in part to
formalize its role as an overseer, supporter
and critic of the heart disease work of
public agencies concerned with the pub-
lic’s health.
Private foundations, like public char-
ities, usually have particular goals for their
funding. Grants from foundations can
provide early flexible support that will
help you start new projects before your
first major federal grant or open up new
lines of research once you have a federally
funded main line project under way.
The Burroughs Wellcome Fund
(BWF), where the author of this review
is a senior program officer, is in many
ways typical of foundations working in
the scientific arena. The organization’s
programs are managed by scientists on
staff. Started in 1955 as the corporate
foundation of Burroughs Wellcome Co.
(BWCo), a discovery-focused pharmaceut-
ical company, BWF became an independ-
ent foundation in 1994, shortly before
the takeover of BWCo’s parent company
by Glaxo PLC.
In its early years, BWF supported
academic science, often providing early
career development for junior faculty who
would become leaders in fields related to
the discovery, development, and safety
of new drugs—areas like pharmacology,
toxicology, and experimental therapeutics.
Also supported was work on under-
studied infectious diseases, primarily the
then poorly understood protozoan patho-
gens that have been responsible for con-
siderable human suffering for centuries.
After its independence, BWF expanded its
support of infectious disease research to
include the fungal pathogens, and in 2001,
expanded its support again to include
work across the human pathogens through
the Investigator in Pathogenesis of Infecti-
ous Disease program. BWF also supports
postdoctoral training for clinician scien-
tists; postdoctoral training for physical,
mathematical and computational scientists
moving into the life sciences; graduate
training at the interface of the popula-
tion and bench sciences; reproductive
science; and training programs aimed at
science teachers and students (kindergar-
ten through college), in North Carolina,
where the organization is headquartered.
Most foundations that focus on science
advertise their programs on their web-
sites, are listed in the various funding
databases and services to which universities
subscribe, and broadcast email program
announcements to deans, department
chairs, and departments of sponsored
research across the country.
New foundations relevant to scientists
can appear and evolve rapidly. The Ellison
Medical Foundation, founded in 1997 by
the co-founder of the Oracle Corporation,
began funding parasitic and infectious
diseases research in 2001 and discontinued
support of this field in 2005. The
foundation still exists and concentrates
its resources on funding research on
aging. In 2001, a new research-supporting
foundation, the Flight Attendant Medical
Research Institute, was incorporated and
funded with proceeds from a tobacco
lawsuit settlement. FAMRI supports
research on health problems connected
to second-hand smoking,
29 and thus is a
potential funder for those working with
respiratory pathogens. On the other
hand, in 2008, the billion dollar Picower
Foundation, a major supporter of neuro-
science research, was forced to cut off
funding and closed its doors, having lost
Table3. Largest private foundation supporters of
health science research
Foundation Support
per year,
$millions
Bill and Melinda Gates Foundation 544.8
The Starr Foundation 50.2
The Lincy Foundation 46.8
Eli and Edythe Broad Foundation 35.1
Flight Attendant Medical Research
Institute, Inc.
25.7
Burroughs Wellcome Fund 21.0
Wallace H. Coulter Foundation 20.0
The Simons Foundation 13.8
The John A. Hartford Foundation, Inc. 12.0
James S. McDowell Foundation 11.3
Source: The Foundation Center. Note: The
Howard Hughes Medical Institute is not incorpo-
rated as a private foundation.
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all of its money to Bernie Madoff’s Ponzi
scheme.
30
Some foundations are designed to exist
for a set time: the Whitaker Foundation,
incorporated by the founder of the elec-
tronic manufacturer AMP Inc., was a
major sponsor of biomedical engineering
research, spent out its endowment in
2006.
31 The Louise P. Markey Charitable
Trust, founded by an heiress to the
Calumet Baking Powder fortune, was
launched with the plan that it would cease
existing 15 years after its founder’s death.
The Markey Trust was a major funder of
health science research and developed the
first postdoc/faculty bridging grant pro-
gram. As the Markey Trust entered its
final years, it worked with the National
Academy of Sciences to set up a thorough
evaluation of its programs. This evalu-
ation, published in five parts by the
National Academies Press,
32 is having a
lasting impact on how foundations build
funding programs in the sciences.
Risk capital. NIH and NSF both have
mechanisms (discussed below) that sup-
port exploratory research and pilot work
on high risk/high payoff ideas. Founda-
tions and public charities have followed
the Bill and Melinda Gates Foundation’s
lead in creating “Grand Challenges” pro-
grams meant to stimulate development of
new approaches to fundamental questions
or to overcoming roadblocks to advancing
human health.
DARPA’s Young Faculty Award,
33 in
place since 2006, supports untenured
faculty and provides not only funding
but also networking and mentoring toward
establishing a faculty research career that
includes significant attention to problems
of interest to national security issues.
Which Grant Fits?
Before you start writing grants, it is
important to understand how a grant
proposal works and how it will be scored.
Each funder has its own approach to
science, its own goals, and its own mission,
which is usually easily found on its website
or through various grant databases. It is
important to learn what drives any funding
organization you hope to have support
your work. Even among agencies that
support the kind of work you do, not
every agency is right for every specific aim.
Just as you will eventually have different
collaborators for different projects, you
should someday have relationships with a
number of funding organizations, each
supporting work that aligns with its own
mission.
NIH’s mission is to seek fundamental
knowledge about the nature and behavior
of living systems and the application
of that knowledge to enhance health,
lengthen life, and reduce the burdens of
illness and disability.
34
The mission of the NSF was set forth
in the National Science Foundation Act
of 1950 (Public Law 81–507).
35 The
agency works “To promote the progress
of science; to advance the national health,
prosperity, and welfare; to secure the
national defense, and for other purposes.”
It supports research in all areas of
engineering, math, and science except
medicine.
36 The Act authorized NSF to
support basic scientific research and engin-
eering research, strengthen the nation’s
capacity in science and engineering, sup-
port science and engineering education
and inform policy formation. Even though
NSF’s mission mentions the national
health, during the four years it took the
National Science Foundation Act to
become law, the NIH extramural program
expanded and developed. By the time
NSF was launched in 1950, NIH had
already become America’s health science
funder.
37
Though NSF is not a health science
oriented funder, it is a key life science
funder. New investigators who are inter-
ested in virulence may identify funda-
mental biological questions that will
advance their work but that will not be
focused on the mechanism of disease.
The missions of the DOE, VA and
other agencies also tell you what you
need to focus on when asking them for
support. In DOE’s mission, “to ensure
America’s security and prosperity by
addressing its energy, environmental and
nuclear challenges through transformative
science and technology solutions,” the
word “transformative” tells you something
important about the scope of work that
they are seeking. Likewise, the VA’s
mission, “To care for him who shall have
borne the battle and for his widow and
his orphan,” tells you that it is first the
veteran, not first the disease, that is the
driver of a potential VA intramural
collaborator’s scientific work.
Missions of private funders also tell you
what to concentrate on. Some disease-
focused organizations care most about
finding cures; others care most about
relieving human suffering. If an organiza-
tion tells its own story in terms of
improving the daily lives of people who
suffer from a disease, it is a mistake to
lead a proposal to that organization with
a paragraph that is all about a molecular
process. Better to look at your work
through their lens and ask which projects
within the reach of your laboratory could
reasonably be discussed in terms of
improving quality of life in the near term
rather than in terms of the work leading
to a better understanding of the disease.
Sometimes this is a matter of gran-
tsmanship: it makes sense to mirror a
funder’s language when writing proposals.
But sometimes your work is simply not
right for a given funder or solicitation.
The Bill and Melinda Gates Foundation,
whose mission is “to increase opportu-
nity and equity for those most in need,”
focuses on areas where their philanthropic
investment in measurable interventions
can bring about change. Important, valu-
able scientific work on pathogens that
cause considerable suffering is often
simply not ready to be turned into the
kind of practical, field-testable project that
the organization is seeking to fund, and
application of skilled grantsmanship will
not make it any readier for an opportunity
that does not fit.
Each funder sets priorities, often through
periodic specific planning activities that are
fairly transparent. At NIH, with congres-
sional oversight, the Director, currently
Francis Collins, sets the organization’s
course. The NIH Roadmap, the increased
focus on translational research, and
Director’s awards programs, are efforts that
cross all of the Institutes. Within NIAID,
the National Allergy and Infectious
Diseases Advisory Council, usually just
called “Council” serves as the advisory
committee for the Institute. Council has
24 members, including 18 voting mem-
bers and six non-voting ex officio mem-
bers who represent the Institute, the
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National Institutes of Health, the Depart-
ment of Health and Human Services, the
Centers for Disease Control and Prevention,
the Department of Veterans Affairs and the
Department of Defense, which share
important interests with the Institute. Of
the18votingmembers,sixarelaypeopleand
12 are scientists who bring to Council not
only technical expertise but experience in
different sectors, including academia and
industry. Council has four roles: providing
secondary level review after study sections do
the primary review; providing policy advice
to the Institute, reviewing programs; and
approving concepts prepared by the various
NIAID Divisions. Concepts are the earliest
stage of new initiatives: they are the ideas
around which new requests for applications,
program announcements, and requests for
proposals are built.
At the National Science Foundation,
policy is set by the National Science Board
(NSB), a panel of up to 25 members
appointed by the President of the United
States and confirmed by the Senate. NSB
is apolitical, with members coming from
universities and industry across the spec-
trum of scientific fields served by the
agency. BWF is governed by a 12 member
board comprised predominantly of highly
accomplished basic and clinical scientists.
Non-scientist members of the board are
often drawn from science-related industry.
Voluntary public health agencies’ direc-
tions are often set by boards that include
scientists, lay people, those affected by the
diseases that are the agency’s focus, and
more.
Which grant when? There are many
opportunities available to write grants, so
it is tempting to chase grants that are
especially large, or prestigious, or that
have a deadline convenient to your work-
flow. But writing the wrong proposal for
a given grant opportunity is a serious
mistake. A proposal that over-reaches—for
example, one that contains far too many
aims for the grant’s time frame, or that
promises more work than can possibly be
done with the funds available—may strike
one reviewer as naïve, another as foolish
and a third as dishonest. None of these
impressions is helpful.
Each year there are dozens of competi-
tive grant programs aimed at new investi-
gators, some requests for proposals that
aim at researchers in your field. At the
same time, there are multiple federal
deadlines for investigator initiated pro-
posals each year. You cannot write a pro-
posal for every solicitation that fits you,
and if you try you will not have enough
time to achieve everything else you need
to get done in your early faculty career.
You will be more successful if you write
proposals only when you have a good
chance of getting them funded. Not every
funding opportunity that is relevant to
your field will fit you or fit your work.
Some will be clearly aimed at another
career stage. Others may be meant to
support projects larger or smaller than the
one that you have in mind. Some will have
deadlines too soon for you to meet or too
far away to be useful. Most substantial
funders have program officers, staff scien-
tists who administer the agency’s grant
portfolios. Getting to know the program
officers at the organizations that are most
likely to fund your work is an excellent
use of your time because they can give
you valuable insight into whether what
you hope to submit will be competitive
for the grants programs that they manage.
Most new investigators need to spend
the first years of their faculty appoint-
ment demonstrating independence from
those who trained them, by developing
and publishing work that is clearly
separated from what they accomplished
at the end of their postdoctoral training.
Startup funds support this early work, as
do many of the New Investigator grants
from private funders.
Postdoc-to-faculty bridging awards,
which bridge the gap between postdoctoral
training and independence, have become
more common but are still rare. Today
the most prominent bridging grant is
NIH’s Pathway to Independence Award,
the K99/R00. NIH’s “K” series grant
mechanisms are career development
awards,
38 and “R” series mechanisms are
research project grants
39 that support
independent investigators. The K99/R00
supports mentored postdoctoral training.
Once hired into a tenure track faculty job
or its equivalent, the award recipient’s
work is reviewed and if it is judged
adequate, the awards can continue with
the faculty level R00 segment of the
award. Funding of the second step is not
guaranteed—it is possible to lose the
award after the postdoctoral stage is
reviewed.
NIAID does not fund many K99/R00
awards, preferring to support a different
mechanism, the Research Scholar Deve-
lopment Award (K22). The K22 provides
early career researchers two years of
support to help them as they make the
transition from mentored trainee to inde-
pendence. Open to US citizens, non-
citizen US nationals (people born in
American Samoa, Swains Island, or the
US Minor Outlying Islands) and US
permanent residents, the program targets
postdoctoral fellows who are about to go
on the job market. Applications undergo a
two part review. The first part, submitted
as a postdoc, is reviewed for merit. Those
who receive a fundable score may then
submit the second part after they have
gained an independent tenure track faculty
position or its equivalent. The award
provides up to $150,000 in its first year
and up to $100,000 in its second.
Two other NIH mechanisms can be
useful in building preliminary data that
can grow to support an R01. Designed as
pilot funding for new or risky projects,
R21 and R03 grants support small-scale
research projects, exploratory and develop-
mental research.
40 R03s, or small research
grants, provide up to $50,000 per year
for up to two years of work on pilot
projects, small self-contained projects, and
new techniques or technologies. R21s, or
exploratory/developmental grants, provide
up to $175,000 for one year or up to
$275,000 total for two years for work
on new ideas, as well as for tool and
technology development work that may
lead to a leap forward for the field in
which the work is done. Both of these
awards may be a good fit for new assistant
professors, but both have innovation
elements that are important to gaining
support. Consulting with a program
officer will help you decide if one of
these mechanisms will really fit the pro-
posal you are considering submitting.
A number of private grants are available
for early stage new investigators, as well.
The Infectious Disease Society of America
(IDSA) has two young investigators pro-
grams, one of them focused on vaccines.
Both are aimed at faculty who do not yet
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have R01s. The Searle Scholars program
supports only researchers who are close to
the date of their faculty appointment. The
American Heart Association’s National
Scientist Development Grant program,
which supports work broadly related to
cardiovascular disease and stroke, fits some
researchers working in infectious diseases
and supports researchers who are in the
first four years of their faculty appoint-
ments. A Young Investigator program
from the Arnold and Mabel Beckman
Foundation aims to support invention of
tools, methods, and materials that will
open up new areas of research. Your
institution will provide you with access
to grant databases and often with lists of
opportunities aimed at your career stage
or broad area of interest. Because so many
private funders offer early faculty grants
meant to stimulate work on the funders’
specific interests, it is a good idea to read
announcements very closely to see if a
broadly named grant is, in fact, narrower
in interests than it appears. Likewise, it is
worth browsing solicitations that do not
seem to fit you to see if they have
unexpected breadth. Many private funders
post lists of those who have gotten their
awards, as well as of members of their peer
review committees. These, too, provide
valuable clues about whether a proposal
on your work would have a good chance of
being funded by a particular organization.
Looking for solicitations that specifi-
cally fit your work rather than your career
stage is effective as well. NIH Requests
for Applications (RFAs) and Program
Announcements (PAs) advertise funding
opportunities that can be quite specific.
They can reflect priorities of NIH as a
whole or priorities of an Institute. These
sometimes come with their set aside fund-
ing, rather than competing with proposals
addressing other topics, but they are not
easier grants to get. When applying for
these opportunities, you are usually com-
peting with the best and most well
established people in your field. If you
are not ready to successfully compete for
an RFA or PA, writing investigator initi-
ated proposals that address these priorities
is a good strategy for getting funded.
Talking with the program officer listed
in the request or announcement under
Scientific/Research Contact(s) will help
you gauge your chances of putting in an
application that will compete well for
funding. Helping you understand whether
your planned proposal fits into their
program and recommending other pro-
grams where your work might fit is a
core element of a program officer’s job.
At NIH, within the National Institute
of Allergy and Infectious Diseases in
mid-2011 there were about 200 program
officers. Researchers in your field will be
able to advise you on who among the
agency’s program officers are managing
programs covering the kind of work that
you would like to get funded.
NSF uses Program Descriptions,
Program Announcements, and Program
Solicitations to communicate opportuni-
ties to investigators. While program des-
criptions and program announcements
are made to highlight programs that use
the generic NSF grant format, which is
published in their Grant Proposal Guide,
19
program solicitations announce opportun-
ities that are more focused and usually last
for a limited time. These programs may
have different submission and review pro-
cesses than most NSF programs and may
limit the number of proposals a researcher
or an institution may submit. NSF pro-
grams sometimes incorporate letters of
intent or preliminary proposals, which
allow researchers and the agency to invest
less time in unfunded proposals when a
program’s funding rate is expected to be
especially low.
What Does It Take to Get a Grant?
What do you want to accomplish in
science? What are the BIG questions that
will drive you for the next 30 years, and
how does that then define what you must
accomplish in the next three years? What
are the key hypotheses you must test now,
and are you proposing the right set of
experiments to get there? Can you really
accomplish what you say you can?
The proposals you write throughout
your career will have different scopes, but
they should never be trivial or grandiose.
Knowing what is practical and possible is
critical to demonstrating true independ-
ence. When you are in training, you begin
to understand what can be accomplished
in the scales of weeks, months and years.
Many leave their training understanding
the costs of their own experiments, but
the costs of running the whole lab are
usually not well understood by students
and postdocs. If you are not yet confident
with your ability to plan budgets, you
should draw on the expertise of colleagues
and your department’s grant administrator
to help you set reasonable budgets. In
FY2009, the median single year direct cost
of an R01 was $250,000 and the mean
was $258,000.
41
NIH uses five core review criteria:
significance, approach, innovation, investi-
gator, and environment.
42 A number of
other factors, including protections for
human subjects; inclusion of minorities,
both genders, and children in clinical
research; involvement of vertebrate ani-
mals; provisions for dealing with bioha-
zards; and whether the proposal is a
resubmission, renewal, or revision, were
made additional review criteria in fiscal
year 2010. They are not scored separately
but are considered in a proposal’s scoring.
Plans for sharing new resources developed
during a project, safety and monitoring
plans for work involving select agents, and
the appropriateness of a proposal’s budget
and period of support, are also considered
during NIH review.
The significance score reflects whether
the problem the proposed work will
address is important, how knowledge or
practice will advance if the aims are
achieved, and its potential impact on the
field. The approach score rates the reason-
ableness and workability of the proposed
project, and whether the work will be a
fitting approach to achieving the proposal’s
specific aims, and whether the proposal
shows the investigator understands poten-
tial problems that may arise and knows
how to move forward if the initial plan is
not fruitful. Scores for innovation consider
whether the proposed work is original,
exploring an innovative hypothesis or
taking on an existing barrier in a new
way. The investigator rating indicates
whether the principal investigator is well
trained, productive, suited to doing the
work, is able to get things done, and has
included appropriate collaborators needed
for the proposed project to succeed. The
environment score marks whether the
work will be done in a scientific setting
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that is conducive to success, with the
appropriate pieces—for example, clinical
access and a subject population needed
for doing the work—available. A sixth
score, the overall impact score, is not a
sum of the other five. The overall impact
score asks reviewers to indicate the
likelihood that, as a whole, the proposed
work will have a sustained, important
influence on its field. The overall impact
score reflects whether all of the parts of
a proposal come together as a whole in a
way that matters and will get the job done.
NSF review focuses on only two criteria,
but many of the same factors that NIH
review focuses on are contained within
them. The first criterion, intellectual
merit, comprises factors including how
well qualified the proposed work is;
whether the work is important for advan-
cing knowledge and understanding in the
field in which it is rooted and across
different scientific fields; creativity, origin-
ality or potential to be transformative;
conception and organization of the pro-
posed work; and sharing of resources
created by it. The second criterion,
broader impacts, includes the proposed
activity’s potential for advancing know-
ledge while also promoting teaching,
training and learning; broadening parti-
cipation by under-represented groups;
enhancing the infrastructure for research
and education; potential for being dissemi-
nated broadly; and benefit to society.
19
Private funders score on similar criteria.
At the Burroughs Wellcome Fund, the
Pathogenesis of Infectious Disease pro-
gram is aimed at early but independent
assistant professors. Review of applica-
tions has both scientific and career deve-
lopment elements. Selection is based on
factors that include the applicant’s quali-
fications, demonstrated independence, and
potential to conduct innovative research;
the quality and originality of the proposed
work; its potential to advance the science
in its field; and whether the proposal
brings new experimental approaches to
under-studied questions. Institutional
environment is important for career deve-
lopment, so BWF is clear on its require-
ments for this review criterion. The
environment includes what the work
needs to succeed, and there should be
evidence that the institution has taken, or
is prepared to take, exceptional steps
toward fostering the candidate’s career
development.
Serving as a reviewer can rapidly help
you improve your understanding of what
comprises a fundable grant and of how
scientific review works. CSR offers an
Early Career Reviewer (ECR) program
that allows independent but not yet
funded investigators to participate in
study section up to twice.
43 Having your
proposals reviewed by colleagues and
reviewing their proposals in turn is an
invaluable exercise that can give you more
experience to improve your grant writing.
As you read and critique others’ proposals
you will get a better sense of how language
and structural factors make a persuasive
argument or leave the reviewer doubting
that the proposed work is up to par.
Colleagues’ critiques will highlight the
same problems, inconsistencies and uncla-
rities that will give reviewers pause. Ideally,
by the time it is submitted, your proposal
will anticipate and respond to the concerns
that will arise as a reviewer reads and
follows your logic.
Submitting a proposal takes longer than
you might think. If you are about to write
your first few proposals as an independent
investigator, when you have found an
opportunity that seems right for you, talk
with local mentors, your chair, and other
investigators in your department to make
sure you understand your own institu-
tion’s requirements and timelines. Each
institution has its own procedures
around proposal submissions, and the
time required and bureaucracy level at
your faculty institution may be different
from those at the institutions at which
you trained. You may find that though
you could prepare your narrative proposal
before the funder’s deadline, there will
not be enough time for the whole appli-
cation packet to be completed. If your
work will involve vertebrate animals or
human subjects; select agents—biological
agents and toxins that have the potential
to pose a severe threat to public, animal or
plant health, or to animal or plant pro-
ducts; stem cells; or recombinant DNA,
additional time may be needed for mov-
ing the proposal through the appropriate
committees and preparing adequate docu-
mentation to include in your application.
Your institution will also usually have a
system, with its own deadlines, for decid-
ing who will be nominated for limited
solicitations, funding opportunities that
allow the institution to submit only one
or a few applications. Internal competition
for these nominations may be held con-
siderably in advance of the grant applica-
tion’s deadline. At some institutions, there
is one annual deadline that covers all
limited solicitations, so local decisions
about who can apply can be made nearly
a year ahead of the application deadline.
If you miss your institution’s deadline,
you will not be nominated and cannot
submit a proposal, no matter how well the
solicitation fits you.
Proposals also may require letters from
outside supporters and from collaborators,
which must be submitted by their authors
before the proposal deadline. You should
ask for letters well ahead of time and be
ready to follow up in the weeks and
days before the deadline. If the letters
are required elements of the proposal and
their writers miss the deadline, your whole
proposal will usually be removed from
consideration.
Once a proposal is submitted, review
time can be quite long, and there can also
be a long period between when you know
your proposal will be funded and when the
grant begins to be paid. Understand the
grant maker’s timeline—at NIAID, fund-
ing a proposal can take 5 to 17 months,
12
though AIDS grants, which are submitted
later in the agency’s grant cycle, sometimes
take less time. At NSF, funding takes more
than 6 months.
19 At BWF, 9 months is a
good estimate for the time from submis-
sion deadline until checks go out to those
who have been funded.
Electronic submission of grant propo-
sals has become fairly universal across
funders. For federal grants, you will need
to register at grants.gov, the cross-agency
grant information and proposal submis-
sion site. NIH applications also involve
the agency’s own grant administration
resource, eRA Commons, which also
requires registration. Applications to NSF
require pre-registration at NSF’s admin-
istration and submission site, FastLane.
Private funders’ application information
will direct you to their electronic submis-
sion sites, which also will require you to
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register. At this writing, 40 private funders
use a common submission site, proposal
Central, and require pre-registration there.
Other private funders use their own in
house electronic submissions site or other
commercial sites.
There are many good resources available
on how to write grants (see refs. 4–11),
and to the best of this author’s knowledge,
there are no secrets to be revealed. It is
important that the grants you submit be
well thought out and well written. NIAID
makes available
44 several (currently four)
annotated examples of well-prepared R01
applications, as well as the summary
statements consolidating comments from
members of the study sections that
reviewed the proposals.
In conceiving, developing, writing and
submitting requests for funding, there are
clear mistakes that cripple proposals and
make them poor candidates for support.
With the exception of profound intellec-
tual errors, most flaws in grants can be
fixed, and what is learned in fixing them
can make one a stronger applicant.
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Even if a proposal’s central flaw is in its
fundamental ideas, it can be learned from,
thought through anew and potentially
turned in a new direction. Researchers
who do not have difficulties with the
mechanics of writing should send their
first good draft to mentors and colleagues
for review.
If you are a clear thinker but are
aware that your writing skills are not
good, hiring an editor to work with you
on your grants may be helpful. Friends
and colleagues are often glad to help you
with your writing, but jumbled thoughts
and tortured grammar take much effort
to decipher and your early drafts may
provide them with far more work than
they had intended to take on. A number
of editorial services are listed at the end
of this journal’s Guidelines for Authors.
Whether on campus or at a distance,
working with an editor who specializes
in the health sciences and is familiar with
your field can provide value beyond a
grammar and usage check. A scientifically
skilled editor can help you improve your
choice of words and the structure of your
arguments. Working with this kind of
editor will take some of your time, as the
editor will have to be sure that he or she is
revising the grant in ways that still capture
your intentions. The process can add days
or weeks to the time it takes to prepare
your proposal, but will teach you things
that will help you improve your writing.
As soon as the proposal is a good reflec-
tion of your intentions, send the draft to
colleagues and mentors for a scientific
critique.
NIH’s proposals are now much shorter
than they once were, and private funders’
proposals and those of NSF are also often
relatively short. Though a proposal’s parts
unfold in a particular order—title, abstract
or summary, specific aims, background/
significance, methods, etc., the quality of
the hypothesis and the appropriateness of
the specific aims are the most important
aspects of a proposal. Because proposals
are relatively short, there is little room for
extra information. Every element of the
grant should reinforce the strength of the
hypothesis and your ability to carry out
your aims. You have to communicate
that you are interested in a high-impact
problem, that your hypothesis is a critical
one for addressing the problem, that your
specific aims are smart and achievable,
and that you, yourself, are the right person
to get the job done. If the proposal format
devotes space to methods, you have room
to communicate that you know the right
way to approach the problem and that you
have alternative approaches should your
primary approaches fail. Even proposal
elements that seem routine, descriptions
of the facilities available to you, for
example, should be written in a way that
underscores that your setting will help
ensure that you accomplish your aims.
Many agencies make public information
about who may be reviewing your pro-
posal. When you submit an investigator
initiated proposal to NIH, the Center for
Scientific Review (CSR), which manages
most scientific review within the agency,
will assign it to the Institute that seems
to fit it best, and then to a review panel
within that institute. At NSF and at many
private funders, program officers deter-
mine which reviewers will be assigned to a
proposal. You can include with your
proposal a cover letter describing where
(for NIH) your submission should be
reviewed and the background or interests
of appropriate reviewers. Some researchers
also use cover letters to ask that particular
reviewers not be assigned to the proposal,
usually citing conflicts of interest.
Reviewers approach proposals in differ-
ent ways. Where some might read your
specific aims first, others might first page
through your curriculum vitae or your
budget. Every section should serve you
well as a potential “front door.” Wherever
they begin their review, most reviewers
quickly decide whether your proposal is
not competitive, highly competitive, or
somewhere in the middle. Even something
as short as the proposal’s title, which
becomes a public record if your grant is
funded by a federal agency, matters. At
NIH, the title provides information that
helps the CSR decide which Institute and
review panel should review your grant. A
reviewer encountering a title that doesn’t
fit the proposed work may spend his or
her first few reading minutes trying to fit
what is written in the proposal to the ideas
that were implied by the title.
Following instructions counts when
you submit proposals. Using the wrong
font or font size, exceeding page limits,
using narrower than permitted margins
and other tricks to get more words on a
page can get your grant rejected without
review. Even with the correct type and
margins, the readability of a proposal can
be an issue. Reading text without white
space is difficult and tiring. Breaking
extremely long paragraphs into smaller
ones each focused on one idea and
incorporating relevant figures makes the
proposal more readable. When the pro-
posal is complete and has been given a
final edit for typographical and grammat-
ical errors, convert it to a pdf format and
then make sure that it opens properly
with the most current version of Adobe
Acrobat.
Plan to submit the finished proposal a
few days before the deadline, and follow
up with others, including your institu-
tion’s department of sponsored research
and anyone who is to submit a letter in
support of your application, a few days
early as well. If your proposal has errors
that cause it to be rejected by the grant
agency’s submission system, having left
time to address any problems will let you
make a successful submission. At some
funding organizations, including NIH,
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proposals must successfully pass through
more than one electronic gateway before
they are officially received. If a proposal
does not get through the whole process by
the stated deadline, it is late and generally
not accepted.
If something outside your control
happens that will keep you from submit-
ting on time, contact the program officer.
Natural disasters, major unexpected life
blows and other rare events sometimes
merit short extensions that will keep a
researcher from having to wait until the
next deadline date to submit an applica-
tion that was nearly complete at the time
of the delay.
After a funder receives your proposal, it
will be sent out for review, generally by
two or more active scientists and then
considered in the context of other propo-
sals submitted at the same time. Low
application success rates are common at
this time. At BWF in all competitive
programs, fewer than 10% of applicants
are being funded, and in the Pathogenesis
of Infectious Disease Awards, the fund-
ing rate is around 8.5%. At NIAID, the
payline has been at 10% across research
project grants and has been set at 14% for
new investigators. The low rate of funding
is not a matter of policy. It reflects the
tremendous pressure of researchers pursu-
ing a relatively small number of dollars.
Many proposals will be triaged and will
not go forward to full review. Given the
very low funding level, triage does not
necessarily mean that the rejected pro-
posal was scientifically flawed or poorly
written, though some triaged grants are.
Triage can happen to relatively good
grants when the number of applications
is high relative to the number of grants
that will be made. At NIH, the lower half
of the applicant pool after initial scores
are in are “streamlined” (triaged) and not
discussed at study section. NSF does not
triage proposals.
At NIH and NSF, reviewers’ comments
and scores are communicated to the appli-
cant to help the applicant decide whether
to resubmit. Feedback from private fun-
ders varies and is sometimes not available.
If a funding agency gives you feedback,
whether in the form of reviewer comments
or as a summary, read it, put it away, and
then read it again in a few days when you
will likely be less disappointed, angry,
upset or frustrated. Reviews with substan-
tial comments are most useful. Reviews
that nitpick about unimportant issues can
be confusing. Such comments are often
the equivalent of a polite, embarrassed
cough indicating that the proposal has
problems too big to be succinctly stated.
If you get this kind of comments, you
should share them with your advisors and
ask again for a very frank critique of your
proposal.
Whether or not feedback is given,
talking with the program officer about
what went on when your proposal was
discussed (if it was discussed) and why
your application was not funded is a
good idea. At many organizations, the
program officer runs the peer review
meeting and will have good knowledge
of the discussion around your proposal.
At NIH, a Scientific Review Admini-
strator from CSR runs the review meet-
ing, but program officers are usually
present, or send a delegate to listen for
them, when proposals submitted to their
programs are reviewed. Program officers
might not give you an answer to the
question “Should I resubmit this pro-
posal,” but the things they tell you about
your proposal’s review will give you good
insight into the answer.
If your proposal was reviewed and
scored well but not well enough to get
the grant, you should be very encouraged.
In this circumstance it is almost always
appropriate to revise your proposal, pay-
ing very close attention to reviewer com-
ments and program officer advice, and
then resubmit it as soon as you can. If
you have been given written reviews, each
reviewer comment should be explicitly
expressed in the revision and highlighted
(for example, by underlining or using
bold type). At many agencies, the same
reviewers will see your proposal the second
time through and they will be looking for
your proposal to have been improved per
their comments.
If, and when, your proposal earns a
fundable score and then is funded, the
best thing to do is celebrate. The grant
getting process is hard, and even well-
funded researchers only rarely get to enjoy
this particular moment of success. In the
days after you have been notified that
your grant is in line for funding, you will
learn how to formalize the necessary
assurances for human subjects, animal
use, and more. Then you will learn how
to manage the flow of dollars from your
new grant; and how you and your institu-
tion will interact to report on your
spending and scientific progress. But these
are subjects for another review.
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